Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05230082 · ClinicalTrials.gov registry record · NA

Acupuncture in Myasthenia Gravis (AcuMG)

A NA study of Myasthenia Gravis, sponsored by HealthPartners Institute.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT05230082 is a NA study of Myasthenia Gravis that has completed, run by HealthPartners Institute. The registered enrollment target is 24 participants, below the 190-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05230082, a NA study of Myasthenia Gravis, has completed, sponsored by HealthPartners Institute.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine the effect acupuncture treatment on individuals with a diagnosis of Myasthenia Gravis (MG). A total of 20 people with MG will be enrolled in this study to receive acupuncture treatment 2 times a week for 12 weeks. Participants will be randomized into two groups: 1) Immediate start and 2) Delayed start (12 weeks). The delayed start group will act as a control group for the first 12 weeks, but then receive acupuncture treatment for 12 weeks. It is hypothesized that patients with MG who receive acupuncture treatment will have improved quality of life and activities of daily living compared to no treatment.

Conditions Studied

Interventions

  • OTHER Acupuncture

Study Locations (1)

Minnesota

  • HealthPartners Neuroscience Center - Saint Paul

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2022-05-25
Est. Completion 2024-04-30
Phase NA

Sponsor

HealthPartners Institute

146 total trials

What the Registry Record Tells You About NCT05230082

The ClinicalTrials.gov registry entry for NCT05230082 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (87% lower). The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myasthenia Gravis appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture is the first listed.

NCT05230082 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05230082 about?

NCT05230082 is a clinical study titled "Acupuncture in Myasthenia Gravis (AcuMG)". The purpose of the study is to determine the effect acupuncture treatment on individuals with a diagnosis of Myasthenia Gravis (MG). A total of 20 people with MG will be enrolled in this study to receive acupuncture treatment 2 times a week for 12 weeks. Participants will be randomized into two grou...

What is the current status of trial NCT05230082?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2022-05-25. Estimated completion is 2024-04-30.

What conditions does trial NCT05230082 study?

This clinical trial studies the following conditions: Myasthenia Gravis.

What interventions are being tested in trial NCT05230082?

The interventions under investigation include: Acupuncture (OTHER).

Who is sponsoring clinical trial NCT05230082?

This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05230082 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myasthenia Gravis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.